1.
Ferrario M, Giuliani G. [In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]. Farmeconomia. Health Economics and Therapeutic Pathways. 2017;18(1). https://doi.org/10.7175/fe.v18i1.1315